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Abstract
Uncomplicate regurgitation in otherwise healthy infants is not a disease. It consists of milk flow
from mouth during or after feeding. Common causes include overfeeding, air swallowed during
feeding, crying or coughing; physical exam is normal and weight gain is adequate. History and
physical exam are diagnostic, and conservative therapy is recommended. Pathologic
gastroesophageal reflux or gastroesophageal reflux disease refers to infants with regurgitation and
vomiting associated with poor weight gain, respiratory symptoms, esophagitis. Reflux episodes
occur most often during transient relaxations of the lower esophageal sphincter unaccompanied by
swallowing, which permit gastric content to flow into the esophagus. A minor proportion of reflux
episodes occurs when the lower esophageal sphincter fails to increase pressure during a sudden
increase in intraabdominal pressure or when lower esophageal sphincter resting pressure is
chronically reduced. Alterations in several protective mechanisms allow physiologic reflux to
become gastroesophageal reflux disease; diagnostic approach is both clinical and instrumental:
radiological series are useful to exclude anatomic abnormalities; pH-testing evaluates the quantity,
frequency and duration of the acid reflux episodes; endoscopy and biopsy are performed in the case
of esophagitis. Therapy with H2 receptor antagonists and proton pump inhibitors are suggested.
Background
Regurgitation is defined as the passage of refluxed gastric
content into the oral pharynx whilst vomiting is defined
as expulsion of the refluxed gastric content from the
mouth. The frequency of regurgitation may vary largely in
relation to age and younger infants up to first month of
age are more frequently affected by regurgitation. Gastro-
esophageal reflux (GER) is the backward flow of stomach
contents up into the esophagus or the mouth. It happens
to everyone. In babies, a small amount of GER is normal
and almost always goes away by the time a child is 18
months old. The consensus statements that comprise the
definition of gastroesophageal reflux disease (GERD) in
the pediatric population were developed through a rigor-
ous process [1]. Consensus items of particular note were:
(i) GERD is present when reflux of gastric contents causes
troublesome symptoms and/or complications, but this
definition is complicated by unreliable reporting of symp-
toms in children under the age of approximately 8 years;
(ii) histology has limited use in establishing or excluding
a diagnosis of GERD; its primary role is to exclude other
conditions; (iii) Barrett's esophagus should be defined as
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esophageal metaplasia that is intestinal metaplasia posi-
tive or negative; and (iv) extraesophageal conditions may
be associated with GERD, but for most of these conditions
causality remains to be established. The prevalence and
natural history of gastroesophageal reflux in infants have
been poorly documented. In a recent pediatric prospective
survey, the 12% of Italian infants satisfied the Rome II cri-
teria for infant regurgitation. Eighty-eight percent of the
infants who had completed two-years follow-up period
had improved at the age of 12 months. Only one apart
210 infants turned out to have GERD [2].
Diagnostic investigation of infants who regurgitate, but
gain weight satisfactorily and do not exhibit other signs or
symptoms is not indicated in clinical practice. The North
American Society for Pediatric Gastroenterology, Hepatol-
ogy and Nutrition (NASPGHAN) [3] recommends that,
once other causes of vomiting have been ruled out, infants
presenting regurgitation and irritability should undergo a
two-week therapeutic test involving a hypoallergenic diet
and acid suppression, either sequentially or simultane-
ously. If no improvement is seen, examinations (pH
measurement or endoscopy with biopsy) would be indi-
cated after this period [4]. The non-erosive or exclusively
histological reflux esophagitis responds well to treatment
based on conservative measures and histamine-2 receptor
antagonists (H2RAs), of which the most often used in
pediatrics is ranitidine [5].
Clinical Approach
In children is important distinguishing between normal,
physiologic reflux and pathological one. Most infants
with physiologic regurgitation are happy and healthy even
if they frequently spit up or vomit, and babies usually out-
grow GER by their first birthday. These patients have no
underlying predisposing factors or conditions, growth
and development are normal, and pharmacologic treat-
ment is typically not necessary. Patients with pathologic
gastroesophageal reflux or GERD frequently experience
complications noted above, requiring careful evaluation
and treatment.
Symptoms and signs associated with GER are non-spe-
cific. Regurgitation, irritability, and vomiting are common
both in infants with physiologic GER or GERD [6] and in
infant with other diseases such as food allergy [7], persist-
ent crying [8] and so on. Cough and anorexia/feeding
refusal were more common in children 1 to 5 years of age
than in older children [9]. Several attempts have been
made to introduce specific questionnaire in order to eval-
uate the role of single gastrointestinal symptoms or cluster
of symptoms, calculating the discriminative power of the
symptom score in patients and controls. In a recent study
the items of a validated questionnaire were tested against
the pH esophageal 24-h study in children with suspected
GERD. Regurgitation/vomiting yielded the best symptom
discrimination, and was reported by 46% with abnormal
versus 24% with normal pH-study results. A weighted
score including the five best discriminating symptoms was
positive in 75% versus 44% [10]. Comparing children
with abnormal pH studies and healthy controls, a correct
diagnosis based on five symptoms could be obtained in
75% and 94%, respectively. Overall, questionnaires are
poorly predictive for the severity of gastroesophageal
reflux disease, as they do not correlate with esophageal
acid exposure as measured by pH-metry and with
esophagitis as evaluated by histology of esophageal biop-
sies [10,11]. The role of the history and physical examina-
tion of a child suspected to have GER(D) is to exclude
other disorders that present with the same gastrointestinal
symptoms and to identify complications of GERD [12].
Diagnostic Instrumental Approach
As reported above, a diagnostic approach for the "happy
spitter" infants, gaining weight satisfactorily and without
other signs or symptoms, is not needed. However, diag-
nostic instrumental tests can be performed in infants fre-
quently present complications, in which it is not easy to
identify individuals who truly have GERD. The list of cur-
rent available diagnostic tools in the management of
GERD are reported in table 1.
Esophageal pH monitoring
Ambulatory 24-h esophageal pH monitoring is currently
the best available test for quantifying esophageal acid
exposure, particularly in patients presenting with atypical
symptoms. Esophageal pH recording provides quantita-
tive data on both esophageal acid exposure and on the
correlation between patient symptoms and reflux events.
Esophageal acid exposure is defined by the percentage of
the 24-h recording time that the pH is < 4.0. Values > 3.5%
are considered abnormal. However, pH monitoring is of
limited use in preterm infants whose gastric pH is >4 for
the 90% of the time making it almost impossible to detect
GER by this technique [13,14]. Wireless pH monitoring
has superior sensitivity to catheter studies for detecting
pathological esophageal acid exposure because of the
extended period of recording (48 hours) and has also
shown superior recording accuracy compared with cathe-
ter equipment. The American Gastroenterological Associ-
ation (AGA) reported that ambulatory impedance-pH,
catheter pH, or wireless pH monitoring (proton pump
inhibitor (PPI) therapy withheld for 7 days) is useful to
evaluate patients with a suspected esophageal GERD syn-
drome who have not responded to an empirical trial of
PPI therapy, have normal findings on endoscopy, and
have no major abnormality on manometry [15].
Although important contributions have been made to
assess the diagnostic value of the long-term pH monitor-Italian Journal of Pediatrics 2009, 35:39 http://www.ijponline.net/content/35/1/39
Page 3 of 12
(page number not for citation purposes)
ing in any age pediatric groups, only few reports in chil-
dren have attempted to correlate the pH pattern of reflux
with the clinical severity of gastro-oesophageal reflux dis-
ease and to determine the ability of the test to differentiate
normal subjects from patients with various degrees of
reflux disease [16,17]. The reproducibility of the intralu-
minal oesophageal pH test to discriminate patients with
various degrees of reflux disease have produced contradic-
tory results [18,19]. The 24 hour intraesophageal pH
monitoring may present false negative results that limit
overall sensitivity of the test. Several scoring systems for
pH monitoring studies have been developed [20,21] but
any system is clearly better than reflux index (RI) [22].
Development of esophagitis was associated with
increased acid exposure of the esophagus. The number of
reflux episodes lasting more than five minutes was the
most significant variable that differentiated patients with
esophagitis from those with simple gastro-esophageal
reflux disease. The five minute value is currently regarded
as the most accurate variable in predicting the occurrence
of esophagitis because it reflects the mechanisms of
esophageal acid clearing. However, symptoms may not
correlate with acid exposure or the presence of esophagi-
tis. This may be because symptoms may result from non-
acidic as well as acidic refluxate [23]. A surprising finding
relates to the fact that reflux during sleep was not impli-
cated in the occurrence of esophagitis. It is commonly
assumed that reflux occurring during sleep can be more
dangerous to the esophagus than the awake acid exposure
as acid clearing is usually impaired during sleep [24].
Reports on adults have produced strong evidence that
nighttime heartburn and GER represent a distinct clinical
entity which deserves specific attention in the diagnosis
and optimal treatment of GERD [25]. The discriminating
power of the pH test is optimal for long lasting recording,
even the postprandial esophageal integrated acidity pro-
vides a robust estimation of esophageal acid exposure and
may predict symptoms in gastro-esophageal reflux disease
patients [26]. However, in infants milk or formula feeding
can neutralize gastric acidity, so reflux of non-acid gastric
content might not be detected by pH test [23].
Multiple intraluminal esophageal impedance
Gastroesophageal reflux can be acid, nonacid, pure liquid,
or a mixture of gas and liquid. Esophageal pH and imped-
ance were used to identify acid reflux (pH drop below
4.0), minor acid reflux (pH drop above 4.0), nonacid
reflux (pH drop less than 1 unit + liquid reflux in imped-
ance), and gas reflux [27]. Non-acid reflux is a particular
problem in pediatrics because children are fed more fre-
quently than adults and the majority of non-acid reflux
occurs in the post-prandial period when stomach content
is neutralized.
Additionally, there are many children that are continu-
ously fed through gastrostomy tubes such that the pH of
the stomach is neutral for the majority of the day. Other
factors can explain a negative pH monitoring in subjects
with gastro-esophageal reflux disease. First, episodes of
alkaline gastroesophageal reflux might be overlooked
using the standard routine pH measurement. Increased
flow/volume of saliva can reduce the exposure acid time
of the esophagus neutralising the acidity of the refluxed
content [28]. Esophageal bile reflux seems to play an addi-
tional role in the pathophysiology of gastroesophageal
Table 1: List of current available diagnostic tools in the management of GERD
Exam Advantages Disadvantage
24 h Esophageal pH monitoring Gold standard for acid reflux
Reference data available Reproducibility
Portability
The probe is often disconfortable
Non acid or gas reflux are not detected
Esophageal manometry Identification of the GER mechanisms
Evaluation of the esophageal and sphincter motility pattern




Endoscopy Description of esophageal mucosal damage
Biopsy allows histological description
Anesthesia is needed
Trained personnel




Scintigraphy Study of gastric emptying Radiation exposure
Not portableItalian Journal of Pediatrics 2009, 35:39 http://www.ijponline.net/content/35/1/39
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reflux disease [29]. A third possible explanation for a neg-
ative pH result in patients with gastro-esophageal reflux
disease lies in the variability of the prolonged
intraesophageal pH monitoring. In fact, milk fed infants
had been reported to have a low reflux index reflecting
prolonged buffering of gastric acidity rather than the
absence of reflux [30,31].
Previous pediatric studies have shown that between 30-
88% of reflux in children is non-acid [32]. The literature
has focused on the role that acid reflux plays and cur-
rently, it is thought that non-acid reflux may be involved
in the pathogenesis of respiratory diseases [33]. Children
under the age of 18 months have the highest rates of acute
respiratory diseases of any age group. Many of these acute
illnesses progress to chronic respiratory diseases such as
asthma, which result in significant morbidity and mortal-
ity [34]. Despite excellent medical therapy, the prevalence
rates of chronic respiratory disease remain high.
A recent work have attempted to characterize the propor-
tion of acid and nonacid esophageal reflux events in
young infants with suspected GER using combined pH-
multichannel intraluminal impedance (pH-MII) moni-
toring. To determine the symptom index correlation with
nonacid reflux and acid reflux events in children, aged 2
weeks to 1 year, 1890 reflux events were detected by pH-
MII, and 588 reflux events were detected by pH probe
alone. The percent of reflux that was acid was 47% versus
53% of nonacid reflux events. The proportion of nonacid
reflux decreased with age and with increasing time elapsed
from last meal. The most frequently reported symptom
was fussiness/pain, which correlated with nonacid reflux
events 24.6% and acid reflux 25.2%. The proportion of
nonacid reflux to acid reflux events in infants was more
similar to adults than previously reported. Combined pH-
MII esophageal monitoring identifies more reflux events
and improves clinical correlation with symptoms [35].
The pH-MII catheter is a small tube that is inserted
through the nose into the esophagus and is identical in
size to the standard pH probe. The catheter remains in
place for 24 hours during which it continuously measures
the amount of both acid and non-acid reflux that is enter-
ing the esophagus from the stomach. Another significant
advantage to pH-MII is the ability of the catheter to meas-
ure the height of the refluxed stomach contents; imped-
ance sensors are positioned throughout the esophagus so
reflux extends along the entire length of the esophagus,
and even up into the mouth and potentially the airway,
can be determined. Pediatric studies have suggested that
the pH-MII catheter is as sensitive as the pH probe in the
detection of reflux.
This tool has been very useful in the evaluation of patients
with atypical reflux symptoms (such as asthma, chronic
cough, laryngitis, chest pain) and in patients who con-
tinue to have symptoms while taking acid blocking medi-
cines. Studies in adults and children have shown that the
addition of pH-MII monitoring significantly improves the
physicians' ability to diagnose reflux-related disease. In
studies of infants, the use of pH-MII has been particularly
important in clarifying the relationship between respira-
tory diseases. While the association between apnea and
reflux in infants has been debated, there is some evidence
that non-acid reflux may be associated with breathing
problems in these young patients. In a study of infants
with primarily respiratory symptoms who underwent pH-
MII testing, the standard pH probe failed to detect 88% of
reflux episodes that were associated with breathing prob-
lems [36]. There is also literature that suggests that non-
acid reflux in children, as well in adults, may be associated
with other respiratory symptoms. In particular, in chil-
dren with severe respiratory disease who were taking acid
blocking medicine, non-acid reflux seems more likely to
be associated with respiratory symptoms than acid reflux.
In pediatrics, pH-MII has been used to evaluate other
reflux therapies such as body positioning [37], apnea of
premature infants [38], and thickening of feeds [39]. All
of the therapeutic studies have involved a small number
of patients and additional data on the treatment of non-
acid reflux are needed.
Because the understanding of the role of non-acid reflux is
in its infancy, very few studies have addressed the treat-
ment options for patients with pathologic non-acid reflux.
Adult and pediatric studies suggest that proton pump
inhibitors such as omeprazole and lansoprazole do not
decrease the total amount of reflux in patients. Instead,
they convert the reflux from acid to non-acid reflux which
may explain why some patients continue to have symp-
toms despite therapy with proton pump inhibitors [40].
Adult studies have suggested that therapy with the drug
baclofen may effectively treat non-acid reflux [41].
Baclofen is a gamma-aminobutyric acid (GABA) agonist
which decreases the amount of esophageal sphincter
(LES) relaxations, the main cause of reflux. However,
because of its evident side effects on the central nervous
system (CNS) (drowsiness, confusion or mental depres-
sion, mood or mental changes, seizures) baclofen is unde-
sirable for use as a treatment for GERD. Further
development work has yielded a number of novel GABA
type B receptor agonists with reduced CNS side effect pro-
files, and clinical trials are currently being performed with
several agents. Compounds that target esophageal sphinc-
ter relaxations may therefore present a new add-on treat-
ment for patients with persistent GERD symptoms despite
PPI therapy.Italian Journal of Pediatrics 2009, 35:39 http://www.ijponline.net/content/35/1/39
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Upper endoscopy and histology
Endoscopy associated with histology is a reliable and
accurate method to demonstrate esophageal damage
induced by GERD, such as inflammation and strictures.
However, up today optimization and standardization of
pediatric endoscopy procedure have not yet realized [42].
The findings of erythema, edema, loss of shine and friabil-
ity in the distal esophagus are aspecific, and the introduc-
ing of controversial parameters for esophagitis diagnosis,
with interpretations varying greatly from one endoscopist
to another, have increased the disagreement between
macroscopic and histological findings. In contrast, the
presence of esophageal erosion is less subject to observer
interpretation [43]. Some authors observed that enan-
thema of the esophageal mucosa may not have any histo-
logical correspondence with reflux esophagitis. Studies
have shown the predominance of disagreement between
endoscopic and histological results in milder cases, while
agreement between the two diagnostic tests predominates
in more severe forms [44]. Hiatal hernia is the only endo-
scopic observation that predicts erosive esophagitis [45].
The use of the Tytgat classification, which does not take
into account the presence or absence of Barrett's esopha-
gus, but describes non-erosive abnormalities observed in
the discrete esophagitis (commonly observed among
infants), may report the endoscopic diagnosis of level I
esophagitis associated with normal histology [46].
All patients with erosive esophagitis presented reflux
esophagitis on histology. The esophageal biopsy plays an
important role, as much in cases of normal examinations
or mild abnormalities as in cases of erosive esophagitis. If
the edema, erythema and friability commonly observed in
children are non-specific, findings from histological
examination and morphometric studies of the esophageal
mucosa allow an etiologic diagnosis of eosinophilic
esophagitis if characteristic alterations such as eosinophil
infiltrates, increased total epithelial and basal cell thick-
ness, and elongation of stromal papillae are seen [47].
Furthermore, histopathology allows the investigation of
other diagnostic possibilities such as infectious esophagi-
tis (Herpes virus, Cytomegalovirus, Candida), Barrett's
esophagus, dysplasia, adenocarcinoma, Crohn disease,
and others. Microscopic evaluation of biopsy samples
from the distal esophagus, but avoiding the most distal
area to minimize the false positive findings at LES, dem-
onstrated abnormalities in many patients who have symp-
toms but no endoscopically evident erosions. Infiltration
of the epithelium with inflammatory cells, the changes
recognizable in esophageal epithelium regardless of ori-
entation of the specimen, received early attention. Neu-
throphils and eosinophils are not normally present in the
ephitelium of the children and can be used as marker of
GERD even though they may be fairly insensitive [48].
Intraepitelial limphocites are more sensitive than other
inflammatory cells but they are very common and so their
specificity for GERD remains unclear.
Eosinophilic oesophagitis results in inflammation the
esophagus, and in most cases are seen in people with
allergies such as hay fever and asthma. There is some evi-
dence that this may be an unusual form of food allergy. It
is important to rule out it since eosinophilic esophagitis
can progress to esophageal stenosis, and not responding
well to anti-GER treatment, corticoid therapy being indi-
cated instead. In such cases, the high eosinophil density (>
20 per high power field) and the presence of eosinophils
in the proximal esophagus favor the hypothesis of eosi-
nophilic esophagitis [49]. To determine the clinical, endo-
scopic, and histologic criteria that distinguish children
with eosinophilic esophagitis (EE) from those with non-
EE diagnoses, a retrospective case-control study was per-
formed for children with any degree of esophageal eosi-
nophilic inflammation who underwent esophageal
biopsy [50]. Although EE and non-EE patients com-
plained of vomiting and abdominal pain at equivalent
rates, EE patients were 3 times more likely to complain of
dysphagia and twice as likely to have stricture formation.
On endoscopy, patients with EE were 19-times more
likely than non-EE patients to have endoscopic abnormal-
ities. Histologically, EE patients were more likely to have
basal zone hyperplasia and degranulated eosinophils
[50]. Although the above mentioned findings, the histo-
logic distinction between EE and GERD cannot be reliably
made on histopathologic evidence alone in children with
upper aerodigestive symptoms. Despite the recent gastro-
enterology consensus statement regarding the clinic-path-
ologic diagnosis of EE, children with primary airway
symptoms in whom EE is suspected represent a diagnostic
dilemma [51].
Motility studies
Motility disorders are postulated to potentially cause
reflux since an association between diminished LES tone,
transient LES relaxations, delayed gastric emptying and
GER have been recognized. Esophageal manometry meas-
ures movement and pressure in the esophagus. In particu-
lar, it measures esophageal motility pattern and
coordinated peristalsis, and the upper and lower esopha-
geal sphincter pressures. There are two main types of man-
ometric recording systems: perfused and solid state. Both
have strengths and weaknesses, and the choice of any par-
ticular system depends on how these strengths and weak-
nesses are viewed. Esophageal motility develops during
infancy and early childhood, and may be influenced by
various factors, including maturation, dietary and pos-
tural habits, arousal state, ongoing illnesses, congenital
anomalies, and effects of medical or surgical interven-
tions. Esophageal motility is particularly important
because it regulates the movement of a bolus during swal-Italian Journal of Pediatrics 2009, 35:39 http://www.ijponline.net/content/35/1/39
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lowing or during GER. Infantile reflux is different from
adult reflux in that regurgitation or vomiting is quite com-
mon, even in normal infants [52]. Despite its common
occurrence, the mechanisms of esophageal and airway
protection during episodes of GER in infants are relatively
poorly understood. None of the current approaches [3]
for the evaluation of GER in infants evaluates the protec-
tive mechanisms. To date, there is not much evidence of
esophageal defense mechanisms against GER in children,
although data exist from adult studies [53,54]. In sum-
mary, carefully performed esophageal manometric studies
in infants and children should include (1) basal measure-
ments of the esophageal body and sphincters; (2) details
of post-prandial state, including the response to wet and
dry swallows; (3) response to esophageal provocation;
and (4) identification of esophageal-protective reflexes.
Such information may be useful in understanding the
pathophysiology of esophageal motor function [55].
Manometric study is useful in identifying transient relaxa-
tions of the LES as a pathophysiological mechanism of
GERD [56] and for the diagnosis of achalasia or other
motor disorders of the esophagus which may present itself
as reflux. Esophageal motor abnormalities are commonly
found in children with esophagitis [57] and in children
with developmental delay and neurologic impairment,
with GERD recurred after Nissen funduplication [58]. As
regard the discriminating role of manometric studies, a
recent study point out that manometry assess only resting
LES pressure and its length in children with acid GER but
do not clearly differentiate GER into primary and second-
ary refluxes to cow's milk allergy [59]. Gastric emptying
studies have shown prolonged half-emptying times in
children with gastroesophageal reflux. The significance of
this phenomenon is not clear. Tests of gastric emptying
are not routinely performed in patients with suspected
GERD, but may become worthy gastric retention is sus-
pected (see scintigraphy and ultrasonography).
Imaging
Radiography
Plain radiographic findings are not useful in evaluating
patients for GERD, but they are helpful in evaluating pul-
monary status and basic anatomy. Esophageal inflamma-
tory and neoplastic diseases are better detected with
double-contrast techniques [60]. Conversely, single-con-
trast techniques are more sensitive for structural defects
such as hiatal hernias and strictures or esophageal rings
[61]. Various techniques are used, and each has relative
strengths and weaknesses in the ability to detect specific
abnormalities or disease processes. A typical barium
esophagram is performed in multiple steps or phases. A
high-density barium suspension is administered, and
double-contrast views are used for images taken with the
patient in the upright position. Prone-positioned images
are typically obtained with single contrast and a lower-
density barium suspension. Mucosal relief images can be
made to complement these techniques.
Early esophagitis is not well demonstrated and decreases
the overall sensitivity of barium swallows [62]. This is why
many clinicians reserve barium swallow for the evaluation
of patients with GERD and symptoms that include dys-
phagia. Barium swallow is not sensitive in the detection of
actual reflux, except in the occasional patient who has a
wide-open LES and free reflux. Radiographic series are nei-
ther sensitive nor specific for diagnosing GERD especially
compared to tests such as 24-hour pH monitoring. The
presence of Barrett esophagus occasionally is detected as a
reticular mucosal pattern. As expected, the more advanced
the esophageal disease, the more sensitive is barium swal-
low at detecting it [63]. Barium swallow is a very impor-
tant study in the investigation and detection of
postoperative complications following fundoplication.
Recurrent hiatal hernia, disruption or slippage of the fun-
doplication, and other structural abnormalities can be
identified [64]. Late postoperative dysphagia can be inves-
tigated by a combination of manometry and esophageal
fluoroscopic examination. Increases in esophago-gastric
transit time of liquid barium and solid boluses correlate
positively with the presence of postoperative dysphagia
[65].
Ultrasonography
Conventional ultrasonography have reported to be a reli-
able non invasive method to detect reflux events and as
well to describe anatomical conditions such as hiatal her-
nia, length and position of the LES and the magnitude of
the gastro-esophageal angle of His. Although conven-
tional sonography is not a diagnostic tool for achalasia, it
provides interesting sonographic information. It cannot
reveal each layer of the wall of the lumen as endoscopic
ultrasound does, but it may tentatively differentiate acha-
lasia from malignancies and assists clinicians when endo-
scopic ultrasound is not available [66]. Few
improvements have been introduced for studying esopha-
geal function, i.e high-frequency intraluminal ultrasound,
whereas conventional techniques, such as manometry,
have undergone substantial upgrades because of advances
in transducer technology, computerization, and graphic
data presentation. Although this techniques provide both
novel and more detailed information regarding the meas-
ure of the esophageal contractility and the thickness of
esophageal muscle, it is still unclear whether they have
improved the ability to diagnose and treat patients more
effectively [67,68]. Ultrasonography is not recommended
as a test for GERD for its low sensitivity and specificity.
Last, dinamic ultrasound may be useful for the study of
the gastric emptying time [69,70]. Antral measurementsItalian Journal of Pediatrics 2009, 35:39 http://www.ijponline.net/content/35/1/39
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are made before and immediately after the end of the test
meal (time 0), and at regular 30-min intervals up to 180
min after the meal. In each patient, the gastric emptying
rate was expressed as percent reduction in antral cross sec-
tional area from time 0 to 120 min after meal ingestion
[71]. Gastric emptying assessed by a non-invasive tech-
nique as ultrasonography is particularly suitable for
young patients even if it is time consuming and investiga-
tor dependent [72].
In young children suspected of GERD, the gastroesopha-
geal junction was examined with ultrasonography directly
after a feeding while these children were on overnight
extended esophageal pH monitoring (EEpHM). The two
tests showed 81% to 84% agreement in the detection of
the presence or absence of GER, depending on whether
the whole period of EEpHM or only the part of it covering
the ultrasound observation period [73]. The two studies
probably measure different aspects of clinically significant
reflux and must be correlated with the clinical symptoms.
Morphological findings associated with significant reflux
were: (1) a short intra-abdominal part of the esophagus,
(2) a rounded gastroesophageal angle, and (3) a "beak" at
the gastroesophageal junction. Barium meal findings con-
firmed these sonographic signs, indicating a sliding hiatal
hernia of the distal esophagus, either fixed or intermittent.
Ultrasonography can be recommended as a useful and
physiological screening test to demonstrate clinically sig-
nificant GER and a predisposing hiatal hernia of the
esophagus in symptomatic children but it is not routinar-
ily used in the diagnosis of GERD.
Scintigraphy
Gastroesophageal reflux and clearance of the refluxed
material can be measured by plotting a time-activity curve
from an esophageal area of interest after 1 mCi of99mTc
sulfur colloid is placed in the stomach. Control subjects
do not have peaks exceeding a value twice that of the base-
line count levels. Reflux patients exceed this value, either
spontaneously or after Valsalva maneuvers. This tech-
nique has a sensitivity which is greater than that of barium
and equal to the sensitivity of a pH probe in patients with
both moderate and severe reflux. Scintigraphic reflux was
shown in 62% of moderate refluxes and 85% of those
with severe reflux as defined clinically. This test can be
performed rapidly with minimal radiation exposure and
is noninvasive [74]. The sensitivity of the milk scan com-
pared to pH probe for diagnosis of esophageal reflux is
15-59% that is low whilst specificity is much higher since
it is 83-100% [75]. Scintigraphy in children with GERD
can provide information on postprandial reflux and
delayed gastric emptying [76]. Besides, the 1-hr scinti-
graphic study formatted in 60-sec frames provides a quan-
titative representation of postprandial gastroesophageal
reflux for children, particularly if they do not have rapid
gastric emptying [77]. Even its ability to identify reflux
and gastric emptying time, the routine diagnosis and
management of GERD in infants and children does not
comprise scintigraphy.
Treatment
The treatment of GER/GERD should be individually tai-
lored according to the clinical manifestation and possible
complications. Treatment options for regurgitation and
GERD include conservative measures, dietary manage-
ment, pharmacologic therapy and surgery. Table 2 con-
tains the strategy step and the grade of recommendation
for each of them [78].
Conservative measures
Because most cases are functional GER, reassurance is the
only treatment needed [79]. Conservative measures may
include upright positioning after feeding, elevating the
head of the bed, prone positioning (infants >6 mo), and
providing small, frequent feeds thickened with cereal
[80]. Older children benefit from a diet that avoids
tomato and citrus products, fruit juices, peppermint,
chocolate, and caffeine-containing beverages. Smaller,
Table 2: Therapeutic options in gastro-oesophageal reflux in neonates, infants and children according with the strategy steps and the 
grade of recommendation
Therapeutic option Strategy Step Grade of recommendation 
Positioning 1 GRADE B (the left lateral position)
Feed frequency 1 GRADE D
Thickened formula or feed 2 GRADE B (for reducing vomiting)
Domperidone 3 GRADE C/D
Ranitidine/cimetidine + PPI 3 GRADE B/C (in relieving esophagitis)
Surgery 4 Surgical intervention is rarely necessary in case of severe complicationsItalian Journal of Pediatrics 2009, 35:39 http://www.ijponline.net/content/35/1/39
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more frequent feeds are recommended, as well a relatively
lower fat diet because lipid retards gastric emptying [81].
Prone positioning may be recommended, at least for the
first postprandial hour [82]. Clearly, the use of the prone
position during infancy must be based on a careful risk-to-
benefit analysis. When it is advised, only very firm bed-
ding material (no pillows) must be used. Bed elevations
offer no added advantage to the prone position, and
seated positions are not recommended.
Dietary management
Although some authors consider conservative therapy to
be an efficient first choice for improving regurgitation
even compared with thickened formula [79], the latter has
been considered a reliable dietary management for
decreasing recurrent regurgitation and/or vomiting in
young infants [83]. Several thickening agents, i.e. rice
cereal, gelatin, carob bean gum or galactomannan, have
been successfully administered for the treatment of regur-
gitation in infants [84,85] and they provide a therapeutic
advantage, particularly when excessive vomiting is associ-
ated with suboptimal weight gain [86]. Even for infants
with normal weight gain, thickened and reduced volume
feedings may reduce the frequency and amount of vomit-
ing episodes, ameliorating the concerns of an anxious car-
egiver. Formula thickened with carob flour, locust bean
gum, rice cereal or rice starch have been found to decrease
episodes of regurgitation and vomiting as well as esopha-
geal acid exposure [83,87]. Undesiderable side effects may
occur, however, with various thickening agents. Orestein
et al. reported an increase in coughing after infants were
fed a formula enriched with rice cereal [88] and Takahashi
et al. reported that soybean fibre decreased food con-
sumption and weight gain in an animal model [89].
Clarke and Robinson [90] reported some cases of fatal
necrotising enterocolitis in infants fed carob thickened
milk.
As a result, the last European Society for Pediatric Gastro-
enterology Hepatology and Nutrition (ESPGHAN) guide-
lines suggested avoidance of formula thickened with
locust bean in infants up to six months because the possi-
ble risk of enterocolitis [91]. Thus, there is a need for alter-
native interventions to thickening agents in infants with
recurrent regurgitation. Probiotic formulas have been
shown to promote a regression of symptoms [71] without
adverse growth or behavioral effects whilst the earlier
demonstration of the safety and tolerance of probiotics in
full term infants makes it suitable for use in this popula-
tion [92]. Further understanding and elucidation of the
mechanisms underlying the beneficial effects of probiot-
ics on gastrointestinal symptoms and motility should pro-
vide new regimens for prevention and treatment of illness
in infants. Another possible diet option could be feeding
the infant with a formula supplemented with prebiotics.
Prebiotics stimulate the gastric emptying so improving
tolerance to enteral feeding, and this would be of clinical
relevance. However, this hypothesis needs further evalua-
tion [93].
The leading symptoms of GERD are present in the case of
cow milk allergy. This disorder should be considered in
preterm infants with recurrent vomiting and irritability
[94]. Confirmation of this diagnosis and treatment con-
sists of a trial of cow milk protein free formula. In some
cases infants are also allergic to hydrolysate and so the
only treatment is amino-acid based formula [13].
Pharmacologic therapy
In the case of pharmacologic intervention, "step-up" ther-
apy involves progression from diet and lifestyle changes
to H2RAs and to PPI [3]. Both classes of acid antisecretory
have proven safe and effective for both infants and chil-
dren in reducing gastric acid output [95]. A specific target
may be children with moderate-to-severe neurodevelop-
mental disabilities who typically have manifest dysphagia
and gastroesophageal reflux, and present a high risk for
aspiration [96,97]. In these patients, conservative therapy
alone may not be sufficient in preventing reflux-associ-
ated complications. Overall, the therapeutic approach of
GERD disease in infants and children needs to be well-
balanced, considering therapeutic efficacy and side effects
of the different therapeutic options [98]. Last, careful
monitoring under optimal nonsurgical therapy should be
conducted before considering operative intervention
[96,99].
H2RAs decrease acid secretion by inhibiting H2 receptors
on gastric parietal cells [100]. The fairly rapid tachyphy-
laxis that develops with H2RAs is a drawback to chronic
use. In some infants, H2RA therapy causes irritability,
head banging, headache, somnolence and other side
effects which, if interpreted as persistent symptoms of
GER, could result in an inappropriate increase in dosage
[101]. H2RAs, particularly ranitidine, are associated with
an increased risk of liver disease, and cimetidine with
gynecomastia [102].
PPIs inhibit acid secretion by blocking Na+, K+ ATP-ase,
the final common pathway of parietal cell acid secretion,
often called the proton pump. PPIs currently approved for
use in children in North America are omeprazole, lanso-
prazole and esomeprazole. In Europe, only omeprazole is
approved. No PPI has been approved for use in infants <
1 year of age. Most studies of PPIs in children have dem-
onstrated the efficacy of PPIs in the controlling of symp-
toms and haeling of erosive esofagitis [103,104]. Children
1-10 yrs of age appear to have a greater metabolic capacity
for some PPIs than adolescents and adults; that is, they
require higher per kilogram doses to attain the same acidItalian Journal of Pediatrics 2009, 35:39 http://www.ijponline.net/content/35/1/39
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blocking effect, or area-under-the-curve [105]. There are
few pharmacokinetic data for PPIs in infants, i.e. lanso-
prazole displays pharmacokinetic and pharmacodynamic
parameters in children between 13 and 24 months of age
similar to those observed in older children and adults
[106]. Infants < 6 months may have a lower per kilogram
dose requirement than older children and adolescents. In
preterm infants and term neonates esomeprazole pro-
duces no change in bolus reflux characteristics despite sig-
nificant acid suppression [107]. Last, a recent study
detected no difference in efficacy between lansoprazole
and placebo for symptoms attributed to GERD in infants
age 1 to 12 months. Severe adverse events, particularly
lower respiratory tract infections, occurred more fre-
quently with lansoprazole than with placebo [108].
Surgery
When medical therapy has failed, or when complications
of gastroesophageal reflux are present [109], the antireflux
operations may include partial or complete fundoplica-
tion and, if possible, the reduction of the hiatal hernia
[110]. As pharmacotherapy has improved, the need for
surgical therapy has markedly decreased. Nevertheless,
antireflux surgery remains one of the most common sur-
gical procedures performed during infancy and early
childhood for refractory erosive oesophagitis or reflux
aspiration [111]. Current guidelines from NASPGHAN [3]
have reported the conditions in which surgery may be sug-
gested. GERD with an atypical presentation, especially res-
piratory, whose symptoms are clearly associated with
gastroesophageal reflux (i.e. obstructive apnea temporally
associated with reflux during pH monitoring) should be
considered for surgical treatment. However, a period of
medical therapy (including acid blockade) under close
monitoring conditions should be attempted in many
cases prior to recommending a surgical approach. Besides,
patients with complications of gastroesophageal reflux,
such as aspiration, stricture of the esophagus, or Barrett
esophagus should be considered for surgical treatment. In
particular, children with pathologic reflux and neurologic
impairment, that requires feeding gastrostomy and con-
tinuous medication should also be considered for surgery.
For those infants who fail medical therapy, continuous
intragastric administration of feeds via nasogastric tube is
an option [112]. It is often used in preterm infants
because of the significantly greater surgical risk in such
patients. In these cases, adequate nutritional manage-
ment, in conjunction with appropriate medical therapy,
may permit the infant to "outgrow" reflux while optimiz-
ing weight gain.
There are no controlled studies of fundoplication versus
medical therapy and studies evaluating different surgical
treatments. In fact, there is no randomization of children
undergoing partial versus complete wraps, even if some
studies suggest that the results of partial one was better
than those of Nissen fundoplication [112]; there are no
clinical trials comparing laparoscopic antireflux surgery
versus open antireflux ones. Only retrospective reviews
and case series have been performed demonstrating lapar-
oscopic antireflux procedures safe and effective once the
learning curve has been achieved [113]. Complications of
fundoplication include dysphagia for solid food, gas bloat
syndrome, wrap herniation and dumping syndrome.
Conclusion
Standard approaches to infants who regurgitate gastric
contents (often the overflow from an overly generous
feeding) differ from that recommended for children who
reflux and have resultant disease manifestations (GERD).
For infants with functional GER, a rational and conserva-
tive approach is to reassure the parents of the benign
nature of the "spitting". Pathologic gastroesophageal
reflux or gastroesophageal reflux disease refers to infants
with regurgitation and vomiting associated with poor
weight gain, respiratory symptoms, esophagitis. In such
case clinical and instrumental diagnosis are needed.
Among the latter upper radiology, pH-testing and MII
testing are useful for diagnosis. Endoscopy and biopsy are
performed in the case of esophagitis. The therapy with H2
receptor antagonist is currently suggested.
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